Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.

The Journal of Experimental Medicine
Alexandra SchäferTimothy P Sheahan

Abstract

SARS-CoV-2, the causative agent of COVID-19, has been responsible for over 42 million infections and 1 million deaths since its emergence in December 2019. There are few therapeutic options and no approved vaccines. Here, we examine the properties of highly potent human monoclonal antibodies (hu-mAbs) in a Syrian hamster model of SARS-CoV-2 and in a mouse-adapted model of SARS-CoV-2 infection (SARS-CoV-2 MA). Antibody combinations were effective for prevention and in therapy when administered early. However, in vitro antibody neutralization potency did not uniformly correlate with in vivo protection, and some hu-mAbs were more protective in combination in vivo. Analysis of antibody Fc regions revealed that binding to activating Fc receptors contributes to optimal protection against SARS-CoV-2 MA. The data indicate that intact effector function can affect hu-mAb protective activity and that in vivo testing is required to establish optimal hu-mAb combinations for COVID-19 prevention.

References

Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Dec 3, 2005·Science·Falk Nimmerjahn, Jeffrey V Ravetch
Jan 19, 2010·Nature Biotechnology·Jonathan ZalevskyJohn R Desjarlais
May 20, 2014·The Veterinary Journal·Niels C Pedersen
Jan 6, 2016·The Journal of Clinical Investigation·David J DiLilloJeffrey V Ravetch
Jun 28, 2016·Nature Reviews. Microbiology·Emmie de WitVincent J Munster
Apr 28, 2017·Annual Review of Immunology·Stylianos BournazosJeffrey V Ravetch
May 6, 2017·Cell·Davide F RobbianiMichel C Nussenzweig
Sep 6, 2019·Proceedings of the National Academy of Sciences of the United States of America·Stylianos BournazosJeffrey V Ravetch
Mar 11, 2020·Cell·Alexandra C WallsDavid Veesler
Jun 20, 2020·Nature·Davide F RobbianiMichel C Nussenzweig
Jul 22, 2020·The Journal of Experimental Medicine·Fabian SchmidtPaul D Bieniasz
Jul 31, 2020·Nature·Noe B MercadoDan H Barouch
Aug 7, 2020·Nature·Kizzmekia S CorbettBarney S Graham
Aug 13, 2020·Nature Reviews. Immunology·Stylianos BournazosJeffrey V Ravetch
Aug 14, 2020·The Journal of Infectious Diseases·Scott B Halstead, Leah Katzelnick
Aug 28, 2020·Nature·Kenneth H DinnonRalph S Baric

❮ Previous
Next ❯

Citations

Jan 27, 2021·Cell·Alessandro Sette, Shane Crotty
Jan 19, 2021·Nature·Christian GaeblerMichel C Nussenzweig
Jan 8, 2021·Clinical Pharmacology and Therapeutics·Alan S Perelson, Ruian Ke
Feb 11, 2021·Nature·Zijun WangMichel C Nussenzweig
Mar 12, 2021·Cell Host & Microbe·Jérémie Prévost, Andrés Finzi
Apr 3, 2021·Cell Host & Microbe·Venkata Viswanadh EdaraMehul S Suthar
Mar 24, 2021·Expert Opinion on Therapeutic Targets·Simone I Richardson, Penny L Moore
Apr 5, 2021·EBioMedicine·Martin S WinklerMarcin F Osuchowski
Apr 22, 2021·MBio·Harini NatarajanMargaret E Ackerman
May 1, 2021·Nature Reviews. Immunology·Deborah CromerMiles P Davenport
Apr 28, 2021·Current Opinion in Virology·Chung-Young Lee, Anice C Lowen
May 12, 2021·Proteins·Wenyang Jing, Erik Procko
May 18, 2021·Cell Reports Medicine·Wen Shi LeeStephen J Kent
Jun 5, 2021·Cell·Davide CortiDavid Veesler
Jun 1, 2021·Cell Reports Medicine·Andrea R ShiakolasIvelin S Georgiev
Jun 14, 2021·Biochemical and Biophysical Research Communications·Dong-Kyun RyuSoo-Young Lee
Jul 9, 2021·Frontiers in Immunology·Christina WoopenTjalf Ziemssen
Jul 14, 2021·MBio·Santosh DhakalUNKNOWN Johns Hopkins COVID-19 Hamster Study Group
Jul 9, 2021·Cell Reports·Madeleine F JenneweinLeonidas Stamatatos
Jul 9, 2021·Nature Communications·Allison J GreaneyJesse D Bloom
Jul 22, 2021·Cell Reports·David R MartinezTimothy P Sheahan
Jul 22, 2021·Cell Reports·Ahmed O HassanMichael S Diamond
Jun 22, 2021·Nature·Rita E ChenMichael S Diamond
Jul 29, 2021·Science Translational Medicine·Neeltje van DoremalenVincent J Munster
Jul 20, 2021·Nature·M Alejandra TortoriciMatteo Samuele Pizzuto
Jul 9, 2021·Nature·Amalio TelentiHerbert W Virgin

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
Assay

Software Mentioned

GraphPad Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.